IMPLANT SCIENCES CORP
IMX
IMX was delisted on the 3rd of April, 2009.
3 hedge funds and large institutions have $37K invested in IMPLANT SCIENCES CORP in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
236% more capital invested
Capital invested by funds: $11K → $37K (+$26K)
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
+$12K |
| 2 |
SAMT
Select Asset Management & Trust
Mechanicsburg,
Pennsylvania
|
+$12K |
Top Sellers
IMX Hedge Fund Activity: Q3 2014 in Review
3 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in IMPLANT SCIENCES CORP (IMX) for Q3 2014, worth a combined $37K — up 236% from $11K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new IMX positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Regent Investment Management, opening a new position worth an estimated $12K.
- 3 institutional investors held IMPLANT SCIENCES CORP (IMX) as of Q3 2014, up from 2 in Q2 2014.
- Funds reported $37K of IMPLANT SCIENCES CORP stock for Q3 2014, up 236% quarter-over-quarter.
- 1 fund opened new IMPLANT SCIENCES CORP positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest IMPLANT SCIENCES CORP buyer in Q3 2014 was Regent Investment Management, an estimated $12K added.
Based on aggregated 13F filings for Q3 2014.